We showed that extracellular cGAMP did not affect the viability of B16 melanoma cells, whereas cGAMP promoted the antitumor activity of splenocytes in a STING-dependent manner (Figure 1A), which indicates that the antitumor effect of extracellular cGAMP depends on host immune cells. This evidence concerns the gene STING1 and melanoma.